Clinical Characteristics and Outcomes of Critically Ill Neurological Patients with COVID-19 Infection in Neuro-intensive Care Unit: A Retrospective Study.
COVID-19
Mortality
Neurocritical care
Neurological functional outcome
Predictors of outcome
Journal
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine
ISSN: 0972-5229
Titre abrégé: Indian J Crit Care Med
Pays: India
ID NLM: 101208863
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
18
12
2021
Statut:
ppublish
Résumé
There are insufficient data about clinical outcomes in critically ill neurological patients with concomitant coronavirus disease (COVID-19). This study describes the clinical characteristics, predictors of mortality, and clinical outcomes in COVID-19-positive neurological patients managed in a dedicated COVID-19 neurointensive care unit (CNICU). This single-center, retrospective cohort study was conducted in critically ill neurological and neurosurgical patients with concomitant COVID-19 infection admitted to the CNICU at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, from July to November 2020. Patients' demographic, clinical, laboratory, imaging, treatment, and outcome data were retrieved from the manual and electronic medical records. Predictors of mortality and neurological outcome were identified using logistic regression. During the study period, 50 COVID-19-positive neurological patients were admitted to the CNICU. Six patients were excluded from the analysis as they were managed in the CNICU for <24 hours. A poor outcome, defined as death or motor Glasgow Coma Scale <5 at hospital discharge, was observed in 34 of 44 patients (77.27%) with inhospital mortality in 26 of 44 patients (59%). Worst modified sequential organ failure assessment (MSOFA) score, lactate dehydrogenase maximum levels (LDH Mortality is high in neurological patients with concomitant COVID-19 infection. Elevated inflammatory markers of COVID-19 suggest the role of systemic inflammation on clinical outcomes. Predictors of mortality and poor outcome were higher MSOFA score and elevated LDH levels. Additionally, lymphopenia was associated with mortality. Surve RM, Mishra RK, Malla SR, Kamath S, Chakrabarti DR, Kulanthaivelu K, et al. Clinical Characteristics and Outcomes of Critically Ill Neurological Patients with COVID-19 Infection in Neuro-intensive Care Unit: A Retrospective Study. Indian J Crit Care Med 2021;25(10):1126-1132.
Sections du résumé
BACKGROUND
BACKGROUND
There are insufficient data about clinical outcomes in critically ill neurological patients with concomitant coronavirus disease (COVID-19). This study describes the clinical characteristics, predictors of mortality, and clinical outcomes in COVID-19-positive neurological patients managed in a dedicated COVID-19 neurointensive care unit (CNICU).
METHODS
METHODS
This single-center, retrospective cohort study was conducted in critically ill neurological and neurosurgical patients with concomitant COVID-19 infection admitted to the CNICU at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, from July to November 2020. Patients' demographic, clinical, laboratory, imaging, treatment, and outcome data were retrieved from the manual and electronic medical records. Predictors of mortality and neurological outcome were identified using logistic regression.
RESULTS
RESULTS
During the study period, 50 COVID-19-positive neurological patients were admitted to the CNICU. Six patients were excluded from the analysis as they were managed in the CNICU for <24 hours. A poor outcome, defined as death or motor Glasgow Coma Scale <5 at hospital discharge, was observed in 34 of 44 patients (77.27%) with inhospital mortality in 26 of 44 patients (59%). Worst modified sequential organ failure assessment (MSOFA) score, lactate dehydrogenase maximum levels (LDH
CONCLUSIONS
CONCLUSIONS
Mortality is high in neurological patients with concomitant COVID-19 infection. Elevated inflammatory markers of COVID-19 suggest the role of systemic inflammation on clinical outcomes. Predictors of mortality and poor outcome were higher MSOFA score and elevated LDH levels. Additionally, lymphopenia was associated with mortality.
HOW TO CITE THIS ARTICLE
UNASSIGNED
Surve RM, Mishra RK, Malla SR, Kamath S, Chakrabarti DR, Kulanthaivelu K, et al. Clinical Characteristics and Outcomes of Critically Ill Neurological Patients with COVID-19 Infection in Neuro-intensive Care Unit: A Retrospective Study. Indian J Crit Care Med 2021;25(10):1126-1132.
Identifiants
pubmed: 34916744
doi: 10.5005/jp-journals-10071-23989
pmc: PMC8645809
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1126-1132Informations de copyright
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.
Déclaration de conflit d'intérêts
Source of support: Nil Conflict of interest: None
Références
J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):218-220
pubmed: 33055146
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
PLoS Med. 2020 Sep 17;17(9):e1003293
pubmed: 32941437
Neurology. 2020 Aug 18;95(7):e910-e920
pubmed: 32444493
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
Am J Med Sci. 2018 Jul;356(1):3-9
pubmed: 30049327
Indian J Crit Care Med. 2020 Oct;24(10):975-980
pubmed: 33281325
Thromb Res. 2021 Jun;202:14-16
pubmed: 33711753
PLoS One. 2020 Dec 15;15(12):e0243710
pubmed: 33320904
Disaster Med Public Health Prep. 2010 Dec;4(4):277-84
pubmed: 21149228
Radiol Cardiothorac Imaging. 2020 Mar 30;2(2):e200047
pubmed: 33778560
Int J Med Sci. 2020 Aug 19;17(14):2225-2231
pubmed: 32922185
J Mol Histol. 2020 Dec;51(6):613-628
pubmed: 33011887
J Neurol. 2021 Sep;268(9):3059-3071
pubmed: 33486564
J Chin Med Assoc. 2010 Mar;73(3):139-43
pubmed: 20230998
Crit Care. 2020 Jul 6;24(1):394
pubmed: 32631393
Cerebrovasc Dis. 2021;50(2):132-140
pubmed: 33530081
Front Med (Lausanne). 2020 Aug 13;7:526
pubmed: 32903492
Can J Anaesth. 2013 Oct;60(10):966-75
pubmed: 23877315
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Neurol. 2021 Aug;268(8):2656-2665
pubmed: 33125542
BMJ Evid Based Med. 2021 Jun;26(3):107-108
pubmed: 32934000
Int J Infect Dis. 2020 Jul;96:291-293
pubmed: 32437939
Brain Behav Immun Health. 2021 Mar;12:100207
pubmed: 33506229
SN Compr Clin Med. 2021;3(4):919-923
pubmed: 33644693
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288